Diagnostic validation of two SARS-CoV-2 immunochromatographic tests in Slovenian and Croatian hospitals
- PMID: 34730892
- PMCID: PMC8596480
- DOI: 10.3325/cmj.2021.62.513
Diagnostic validation of two SARS-CoV-2 immunochromatographic tests in Slovenian and Croatian hospitals
Abstract
Aim: To diagnostically validate two point-of-care (POC) rapid antigen tests for SARS-CoV-2 by comparing their results with those of laboratory-based real-time polymerase chain reaction tests (RT-PCR).
Methods: The study enrolled 455 patients from two Slovenian and two Croatian hospitals. The NADAL COVID-19 Ag Test (Nal von Minden, Moers, Germany) and ALLTEST COVID-19 Antigen Test (Hangzhou ALLTEST Biotech Co., Ltd, Hangzhou, China) were diagnostically validated in emergency care departments of two Slovenian hospitals, while only ALLTEST COVID-19 Antigen Test was validated in two Croatian hospitals.
Results: The antigen test results were in very good agreement with the RT-PCR results (Cohen's Kappa between 0.747 and 0.891 for the NADAL COVID-19 and between 0.820 and 0.954 for the ALLTEST COVID-19). The NADAL COVID-19 Ag Test had the sensitivity between 66.67% and 92.31%, with a negative predictive value between 85.51% and 99.2%. The ALLTEST COVID-19 Antigen Test had the sensitivity between 81.39% and 91.11%, with a negative predictive value between 85.45% and 98.78%.
Conclusion: The antigen tests are practical and reliable screening assays for SARS CoV-2 in emergency care departments. Both antigen tests can be used as screening tests to reduce the number of patients waiting for RT-PCR results. Even more, they can be used to quickly isolate COVID-19 patients and reduce hospital transmissions.
References
-
- European Commission. Coronavirus resurgence: Commission steps up action to reinforce preparedness and response measures across the EU. Available from: https://ec.europa.eu/health/sites/health/files/preparedness_response/doc.... Accessed: October 28, 2020.
-
- European Centre for Disease Prevention and Control (ECDC). Diagnostic testing and screening for SARS-CoV-2. Available from: https://www.ecdc.europa.eu/en/covid-19/latest-evidence/diagnostic-testing. Accessed: October 28, 2020.
-
- World Health Organisation (WHO). Antigen-detection in the diagnosis of SARS-CoV-2 infection using rapid immunoassays. Interim guidance. September 11, 2020. Available from: https://www.who.int/publications/i/item/antigen-detection-in-the-diagnos.... Accessed: September 11, 2020.
-
- SLEDILNIK Covid-19 tracker. Available from: https://covid-19.sledilnik.org/en/stats. Accessed: December 12, 2020.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous